CV Sciences, Inc.CV Sciences, Inc.CV Sciences, Inc.

CV Sciences, Inc.

No trades
See on Supercharts
Market capitalization
‪6.31 M‬USD
‪3.10 M‬USD
‪16.00 M‬USD
‪163.20 M‬
Beta (1Y)
−0.05

About CV Sciences, Inc.

CEO
Joseph D. Dowling
Headquarters
San Diego
Employees (FY)
43
Founded
2010
ISIN
US1266541028
FIGI
BBG0022J68R8
CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the following segments: Consumer Products and Specialty Pharmaceutical. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CVSI is 0.0368 USD — it has decreased by 4.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CV Sciences, Inc. stocks are traded under the ticker CVSI.
CV Sciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CVSI stock is 14.27% volatile and has beta coefficient of −0.05. Check out the list of the most volatile stocks — is CV Sciences, Inc. there?
CVSI earnings for the last quarter are −0.01 USD whereas the estimation was −0.01 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.01 USD. See more details about CV Sciences, Inc. earnings.
CV Sciences, Inc. revenue for the last quarter amounts to ‪3.97 M‬ USD despite the estimated figure of ‪4.26 M‬ USD. In the next quarter revenue is expected to reach ‪4.31 M‬ USD.
Yes, you can track CV Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
CVSI stock has fallen by 2.07% compared to the previous week, the month change is a 5.50% rise, over the last year CV Sciences, Inc. has showed a 24.70% decrease.
CVSI net income for the last quarter is ‪−869.00 K‬ USD, while the quarter before that showed ‪−447.00 K‬ USD of net income which accounts for −94.41% change. Track more CV Sciences, Inc. financial stats to get the full picture.
Today CV Sciences, Inc. has the market capitalization of ‪6.31 M‬, it has decreased by 1.20% over the last week.
No, CVSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CV Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
CVSI reached its all-time high on Feb 21, 2014 with the price of 201.0000 USD, and its all-time low was 0.0263 USD and was reached on Dec 29, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 43.00 employees. See our rating of the largest employees — is CV Sciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CV Sciences, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CV Sciences, Inc. stock shows the sell signal. See more of CV Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CV Sciences, Inc. EBITDA is ‪−2.17 M‬ USD, and current EBITDA margin is −13.90%. See more stats in CV Sciences, Inc. financial statements.